These findings indicate that aplidine prevented angiogenesis in vivo, affecting both physiologic, spontaneous angiogenesis of the embryo, angiogenesis induced by exogenous stimuli (VEGF and FGF-2) and tumour angiogenesis. This evidence concerns the gene FGF2 and neoplasm.